FDA recall record

Tapemark Company iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery recall — FDA Z-0454-2022

The dosage information on the pouch is incorrect; the primary carton label is correct.

Class IIIclassification
Z-0454-2022official record ID
Jan 12, 2022report date

Recall record at a glance

Official recordZ-0454-2022
CategoryMedical Device Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmTapemark Company
Report dateJan 12, 2022
Recall initiation dateNov 10, 2021
Quantity5,141 primary cartons
LocationSaint Paul, MN, United States

Official product description

iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extra Strength, 8-HOUR Average Wear Time, 6/1-patch pouches/box. Dosage: 120mA/min.

Why the product was recalled

The dosage information on the pouch is incorrect; the primary carton label is correct.

Distribution information

US Nationwide distribution in the states of CA, FL, IL, MO, NY, OH, and TN.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.